Price data is not available
Nasus Pharma Ltd
NSRXAMEX
The average analyst price target for Nasus Pharma is $16.50, 522.6% above the current price. Of 3 analysts, 3 rate it Buy. Targets range from $7 to $22. The latest change came on Oct 30, 2026, when Maxim Group initiated coverage of Nasus Pharma with a Buy rating and a $7 price target.
Price Target Range — 4 Quarters
Analyst Consensus — 3 Analysts
Rating Trend — Last 9 Months
